Home Cart 0 Sign in  
X

[ CAS No. 5176-27-2 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 5176-27-2
Chemical Structure| 5176-27-2
Chemical Structure| 5176-27-2
Structure of 5176-27-2 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 5176-27-2 ]

Related Doc. of [ 5176-27-2 ]

Alternatived Products of [ 5176-27-2 ]

Product Details of [ 5176-27-2 ]

CAS No. :5176-27-2 MDL No. :MFCD00209559
Formula : C9H13NO2 Boiling Point : -
Linear Structure Formula :- InChI Key :IZPYBIJFRFWRPR-UHFFFAOYSA-N
M.W : 167.21 Pubchem ID :643494
Synonyms :

Calculated chemistry of [ 5176-27-2 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 5
Fraction Csp3 : 0.44
Num. rotatable bonds : 3
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 46.63
TPSA : 31.23 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.95 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.52
Log Po/w (XLOGP3) : 1.93
Log Po/w (WLOGP) : 2.27
Log Po/w (MLOGP) : 1.43
Log Po/w (SILICOS-IT) : 0.87
Consensus Log Po/w : 1.8

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.2
Solubility : 1.05 mg/ml ; 0.00627 mol/l
Class : Soluble
Log S (Ali) : -2.21
Solubility : 1.03 mg/ml ; 0.00617 mol/l
Class : Soluble
Log S (SILICOS-IT) : -1.67
Solubility : 3.54 mg/ml ; 0.0212 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.74

Safety of [ 5176-27-2 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 5176-27-2 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 5176-27-2 ]
  • Downstream synthetic route of [ 5176-27-2 ]

[ 5176-27-2 ] Synthesis Path-Upstream   1~25

  • 1
  • [ 109-97-7 ]
  • [ 24424-99-5 ]
  • [ 5176-27-2 ]
YieldReaction ConditionsOperation in experiment
94% With triethylamine In dichloromethane at 20℃; for 2 h; Boc2O (9.8 g, 44.7 mmol) and TEA (6.3 mL, 44.7 mmol) was added to pyrrole (25) (3.0 g, 29.8 mmol) in DCM (15 mL) and the resulting mixture was stirred for 2h at room temperature and then worked up with DCM (2 .x. 400 mL) and water (400 mL). The combined organic layers were dried over MgSO4 and were concentrated to obtain 26 as white solid (7.5 g). Yield: 94percent; 1H NMR (300 MHz, CDCl3) δ (ppm) 7.26 (s, 2H), 7.24 (t, J = 2.4 Hz, 1H), 6.22 (t, J = 2.4 Hz, 1H), 1.60 (d, J = 11.7 Hz, 9H); ESI [M + H] = 169.0.
94% With triethylamine In dichloromethane at 20℃; for 2 h; Boc2O (43.65 g, 0.2 mol) and TEA (20.2 g, 0.2 mol)were added to pyrrole (13.42 g, 0.2 mol) in DCM (100 mL)and the resulting mixture was stirred for 2 h at room temperatureand then worked up with DCM (2 x 400 mL) andwater (400 mL). The combined organic layers were driedover MgSO4 and were concentrated to obtain 16 as acolorless oil (31.4 g, yield: 94percent). 1H NMR (600 MHz,CDCl3): 7.27 (s, 2H), 6.25 (s, 2H), 1.62 (s, 9H); 13C NMR(150 MHz, CDCl3): 148.95, 119.98, 111.87, 83.61, 28.01.ESI-MS: m/z 168.4 [M + H]+.
86% With dmap In acetonitrile at 20℃; for 15 h; Procedure: 70 g (1.04 mol) of pyrrole, 274 g (1.25 mol) of di-t-butyl dicarbonate, 17.6 g (0.1 mol) of 4-dimethylaminopyridine and 1 liter of acetonitrile were added to a 3000 ml single-necked flask , The mixture was stirred at room temperature for 15 hours, and acetonitrile was concentrated to obtain a crude product.The crude product was purified by column chromatography using petroleum ether and ethyl acetate eluent system to give 150 g of 1-tert-butoxycarbonylpyrrole (yield 86percent).
78.3% With dmap In acetonitrile at 25℃; for 2 h; Step A: DMAP (1.00 g, 8.2 mmol, 0.14 eq.) was added to a solution of pyrrole (4.00 g, 59 mmol, 1.00 eq.) and(Boc)2O (15.60 g, 71.5 mmol, 1.20 eq.) dissolved in acetonitrile (200 mL). The mixture was stirred at 25°C for 2hours. The mixture was concentrated and the residue was purified by a silica gel column (the eluent is PE) to givet-butyl pyrryl-1-formate (7.80 g, 46.7 mmol, 78.3percent yield) as colorless liquid.
70% With dmap; triethylamine In acetonitrile The starting material was prepared as follows:
Triethylamine (13 ml, 93 mmol), 4-(N,N-dimethylamino)pyridine (100 mg), and di-t-butyl dicarbonate (18.1 g, 83 mmol) were added successively to a solution of pyrrole (5 g, 74.6 mmol) in acetonitrile (125 ml).
The reaction mixture was then heated at 60° C. for 30 minutes.
The reaction was allowed to cool and the solvent was removed by evaporation.
The residue was purified by flash column chromatography eluding with isohexanes/ethyl acetate (100/0 and then 95/5) to give 1-t-butoxycarbonylpyrrole (8.74 g, 70percent).

Reference: [1] European Journal of Organic Chemistry, 2005, # 11, p. 2207 - 2212
[2] Angewandte Chemie - International Edition, 2015, vol. 54, # 52, p. 15739 - 15743[3] Angew. Chem., 2015, vol. 127, # 52, p. 15965 - 15969,5
[4] European Journal of Medicinal Chemistry, 2011, vol. 46, # 4, p. 1153 - 1164
[5] Medicinal Chemistry, 2018, vol. 14, # 5, p. 485 - 494
[6] Chemistry - A European Journal, 2015, vol. 21, # 37, p. 13052 - 13057
[7] Organic Letters, 2016, vol. 18, # 23, p. 6176 - 6179
[8] Beilstein Journal of Organic Chemistry, 2012, vol. 8, p. 1037 - 1047
[9] European Journal of Organic Chemistry, 2014, vol. 2014, # 25, p. 5487 - 5500
[10] Organic Letters, 2010, vol. 12, # 24, p. 5740 - 5743
[11] Chemical Communications, 2016, vol. 52, # 58, p. 9036 - 9039
[12] Patent: CN102875535, 2016, B, . Location in patent: Paragraph 0029-0031
[13] Chemistry - An Asian Journal, 2018, vol. 13, # 3, p. 325 - 333
[14] Organic and Biomolecular Chemistry, 2014, vol. 12, # 28, p. 5071 - 5076
[15] New Journal of Chemistry, 2018, vol. 42, # 13, p. 10472 - 10475
[16] Tetrahedron, 2009, vol. 65, # 34, p. 6877 - 6881
[17] Chemistry - A European Journal, 2017, vol. 23, # 46, p. 10962 - 10968
[18] Patent: EP3248968, 2017, A1, . Location in patent: Paragraph 0077
[19] Journal of Medicinal Chemistry, 1994, vol. 37, # 9, p. 1262 - 1268
[20] Tetrahedron Letters, 2009, vol. 50, # 51, p. 7169 - 7171
[21] Patent: US6265411, 2001, B1,
[22] Angewandte Chemie, 1984, vol. 96, # 4, p. 291 - 292
[23] Patent: US2014/179680, 2014, A1, . Location in patent: Paragraph 0756
  • 2
  • [ 109-97-7 ]
  • [ 1538-75-6 ]
  • [ 5176-27-2 ]
Reference: [1] Organic and Biomolecular Chemistry, 2013, vol. 11, # 26, p. 4327 - 4332
  • 3
  • [ 109-97-7 ]
  • [ 24608-52-4 ]
  • [ 5176-27-2 ]
Reference: [1] European Journal of Organic Chemistry, 2016, vol. 2016, # 21, p. 3509 - 3513
  • 4
  • [ 114221-05-5 ]
  • [ 934-16-7 ]
  • [ 1006-65-1 ]
  • [ 5176-27-2 ]
  • [ 114221-06-6 ]
  • [ 7710-44-3 ]
Reference: [1] Journal of Organic Chemistry, 1988, vol. 53, # 10, p. 2268 - 2274
  • 5
  • [ 82912-39-8 ]
  • [ 49748-48-3 ]
  • [ 5176-27-2 ]
  • [ 82912-40-1 ]
Reference: [1] Synthesis, 1982, # 4, p. 313 - 315
  • 6
  • [ 73286-70-1 ]
  • [ 5176-27-2 ]
Reference: [1] Tetrahedron, 2003, vol. 59, # 49, p. 9729 - 9742
[2] Tetrahedron, 2003, vol. 59, # 49, p. 9729 - 9742
[3] Tetrahedron, 2003, vol. 59, # 49, p. 9729 - 9742
  • 7
  • [ 1122-58-3 ]
  • [ 109-97-7 ]
  • [ 100-36-7 ]
  • [ 5176-27-2 ]
Reference: [1] Patent: US5574017, 1996, A,
  • 8
  • [ 109-97-7 ]
  • [ 34619-03-9 ]
  • [ 5176-27-2 ]
Reference: [1] Tetrahedron Letters, 1994, vol. 35, # 52, p. 9649 - 9652
  • 9
  • [ 696-62-8 ]
  • [ 172282-33-6 ]
  • [ 5176-27-2 ]
  • [ 198981-85-0 ]
Reference: [1] Organic and Biomolecular Chemistry, 2005, vol. 3, # 15, p. 2755 - 2761
  • 10
  • [ 78888-18-3 ]
  • [ 123-73-9 ]
  • [ 5176-27-2 ]
Reference: [1] Synlett, 2011, # 1, p. 124 - 128
  • 11
  • [ 109-97-7 ]
  • [ 1070-19-5 ]
  • [ 5176-27-2 ]
Reference: [1] Angewandte Chemie - International Edition, 2014, vol. 53, # 7, p. 1968 - 1972[2] Angew. Chem., 2014, vol. 126, # 7, p. 1999 - 2003,5
[3] Patent: WO2014/201300, 2014, A1, . Location in patent: Paragraph 00692
  • 12
  • [ 163332-59-0 ]
  • [ 160732-46-7 ]
  • [ 5176-27-2 ]
Reference: [1] Journal of the American Chemical Society, 1995, vol. 117, # 11, p. 3022 - 3028
  • 13
  • [ 1888-75-1 ]
  • [ 114214-49-2 ]
  • [ 5176-27-2 ]
Reference: [1] Tetrahedron, 2003, vol. 59, # 49, p. 9729 - 9742
  • 14
  • [ 594-19-4 ]
  • [ 114214-49-2 ]
  • [ 5176-27-2 ]
Reference: [1] Tetrahedron, 2003, vol. 59, # 49, p. 9729 - 9742
  • 15
  • [ 1822-00-0 ]
  • [ 114214-49-2 ]
  • [ 5176-27-2 ]
Reference: [1] Tetrahedron, 2003, vol. 59, # 49, p. 9729 - 9742
  • 16
  • [ 114221-05-5 ]
  • [ 5176-27-2 ]
Reference: [1] Synthetic Communications, 1997, vol. 27, # 6, p. 1087 - 1096
  • 17
  • [ 109-72-8 ]
  • [ 114214-49-2 ]
  • [ 5176-27-2 ]
Reference: [1] Tetrahedron, 2003, vol. 59, # 49, p. 9729 - 9742
[2] Synlett, 2002, # 2, p. 310 - 312
  • 18
  • [ 75400-57-6 ]
  • [ 5176-27-2 ]
  • [ 1514893-97-0 ]
Reference: [1] Journal of Organic Chemistry, 2014, vol. 79, # 5, p. 1920 - 1928
  • 19
  • [ 109-97-7 ]
  • [ 6627-89-0 ]
  • [ 5176-27-2 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1986, p. 2181 - 2186
[2] Tetrahedron Letters, 2008, vol. 49, # 22, p. 3691 - 3696
  • 20
  • [ 5176-27-2 ]
  • [ 86953-79-9 ]
Reference: [1] Chemistry Letters, 2000, # 4, p. 428 - 429
  • 21
  • [ 5176-27-2 ]
  • [ 135884-31-0 ]
Reference: [1] Chemical Communications, 2008, # 16, p. 1865 - 1867
[2] Journal of Medicinal Chemistry, 2005, vol. 48, # 16, p. 5092 - 5095
[3] Tetrahedron, 2009, vol. 65, # 34, p. 6877 - 6881
  • 22
  • [ 5176-27-2 ]
  • [ 121-43-7 ]
  • [ 135884-31-0 ]
Reference: [1] Inorganic Chemistry Communications, 2015, vol. 54, p. 1 - 4
[2] Angewandte Chemie - International Edition, 2014, vol. 53, # 11, p. 2992 - 2996[3] Angew. Chem., 2014, vol. 126, # 11, p. 3036 - 3040,5
[4] Journal of the American Chemical Society, 2015, vol. 137, # 24, p. 7889 - 7897
[5] Patent: US6391907, 2002, B1,
[6] Patent: US6462032, 2002, B1,
  • 23
  • [ 5176-27-2 ]
  • [ 150-46-9 ]
  • [ 135884-31-0 ]
Reference: [1] Journal of the American Chemical Society, 1998, vol. 120, # 10, p. 2211 - 2217
  • 24
  • [ 768-66-1 ]
  • [ 109-72-8 ]
  • [ 5176-27-2 ]
  • [ 5419-55-6 ]
  • [ 135884-31-0 ]
Reference: [1] Patent: US6265411, 2001, B1,
  • 25
  • [ 5176-27-2 ]
  • [ 22612-89-1 ]
  • [ 736181-18-3 ]
Reference: [1] Tetrahedron, 2004, vol. 60, # 24, p. 5185 - 5199
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 5176-27-2 ]

Amides

Chemical Structure| 4277-64-9

[ 4277-64-9 ]

Ethyl 1H-pyrrole-1-carboxylate

Similarity: 0.90

Chemical Structure| 148760-75-2

[ 148760-75-2 ]

tert-Butyl 1H-pyrrolo[3,2-c]pyridine-1-carboxylate

Similarity: 0.87

Chemical Structure| 75400-67-8

[ 75400-67-8 ]

1-Boc-indole

Similarity: 0.87

Chemical Structure| 1018950-15-6

[ 1018950-15-6 ]

tert-Butyl 1H-pyrrolo[3,2-b]pyridine-1-carboxylate

Similarity: 0.84

Chemical Structure| 475561-75-2

[ 475561-75-2 ]

tert-Butyl 3-bromo-1H-pyrrole-1-carboxylate

Similarity: 0.83

Related Parent Nucleus of
[ 5176-27-2 ]

Pyrroles

Chemical Structure| 4277-64-9

[ 4277-64-9 ]

Ethyl 1H-pyrrole-1-carboxylate

Similarity: 0.90

Chemical Structure| 475561-75-2

[ 475561-75-2 ]

tert-Butyl 3-bromo-1H-pyrrole-1-carboxylate

Similarity: 0.83

Chemical Structure| 175689-35-7

[ 175689-35-7 ]

1-Boc-1H-pyrrole-3-methanol

Similarity: 0.81

Chemical Structure| 72590-65-9

[ 72590-65-9 ]

tert-Butyl 2-methyl-1H-pyrrole-1-carboxylate

Similarity: 0.81

Chemical Structure| 4277-63-8

[ 4277-63-8 ]

Methyl 1H-pyrrole-1-carboxylate

Similarity: 0.79